Tandem Diabetes Care, Inc. (TNDM) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Veracyte, Inc.

AtriCure, Inc.

STAAR Surgical Co.

Integer Holdings Corp.

Tandem Diabetes Care, Inc.

TransMedics Group, Inc.

Pacific Biosciences of California, Inc.

PROCEPT BioRobotics Corp.

NovoCure Ltd.

InMode Ltd.

Alphatec Holdings, Inc.

Why is Tandem Diabetes Care, Inc. ?

Poor Management Efficiency with a low ROE of 0.30%

The company has been able to generate a Return on Equity (avg) of 0.30% signifying low profitability per unit of shareholders funds

With a growth in Net Sales of 5.49%, the company declared Very Positive results in Mar 26

The company has declared positive results for the last 2 consecutive quarters
OPERATING CASH FLOW(Y) Highest at USD 19.6 MM
INVENTORY TURNOVER RATIO(HY) Highest at 3.46 times
RAW MATERIAL COST(Y) Fallen by -9.76% (YoY)

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -25.02%, its profits have fallen by -12.6%

High Institutional Holdings at 100%

These investors have better capability and resources to analyse fundamentals of companies than most retail investors.

Below par performance in long term as well as near term

Along with generating -25.02% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Tandem Diabetes Care, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Tandem Diabetes Care, Inc. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

Tandem Diabetes Care, Inc.

-25.02%

-0.71

96.35%

S&P 500

25.41%

1.92

13.25%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

15.26%

EBIT Growth (5y)

-255.93%

EBIT to Interest (avg)

-9.31

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.01

Sales to Capital Employed (avg)

1.62

Tax Ratio

5.41%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

100.00%

ROCE (avg)

2.83%

ROE (avg)

0.30%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

9.25

EV to EBIT

-16.54

EV to EBITDA

-20.62

EV to Capital Employed

7.50

EV to Sales

1.46

PEG Ratio

Dividend Yield

ROCE (Latest)

-45.34%

ROE (Latest)

-68.79%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Mildly Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

OPERATING CASH FLOW(Y)

Highest at USD 19.6 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 3.46 times

RAW MATERIAL COST(Y)

Fallen by -9.76% (YoY

PRE-TAX PROFIT(Q)

At USD -19.88 MM has Grown at 57.59%

NET PROFIT(Q)

At USD -20.39 MM has Grown at 63.15%

-2What is not working for the Company

DEBT-EQUITY RATIO (HY)

Highest at 124.23 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 7.69 times

Here's what is working for Tandem Diabetes Care, Inc.

Operating Cash Flow

Highest at USD 19.6 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (USD MM)

Inventory Turnover Ratio

Highest at 3.46 times and Grown

In each half year in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Pre-Tax Profit

At USD -19.88 MM has Grown at 57.59%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit

At USD -20.39 MM has Grown at 63.15%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is positive

Net Profit (USD MM)

Raw Material Cost

Fallen by -9.76% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at USD 4.5 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for Tandem Diabetes Care, Inc.

Debt-Equity Ratio

Highest at 124.23 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 7.69 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio